Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

NCT03119883 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Monoclonal Gammopathy of Undetermined Significance
Plasma Cell Myeloma

Interventions

OTHER: 5-Carbon C 13-labeled Glutamine
PROCEDURE: Biospecimen Collection
PROCEDURE: Biospecimen Collection
OTHER: Uniformly-labeled [13C]glucose

Sponsor

Mayo Clinic

Collaborators

[object Object]